Abstract
Objectives
As the number of patients with nontuberculous mycobacterial pulmonary disease (NTMPD) increases, surgical treatment to control disease becomes more important. However, postoperative outcomes and predictors of recurrence have been insufficiently evaluated.
Methods
We retrospectively investigated 100 patients with NTMPD who underwent pulmonary resection from 2009 to 2016 at our institution. Clinical data of patients with and without postoperative recurrence were statistically compared. Recurrence was defined as microbiological re-identification or computed tomography findings highly suspicious for relapse after excluding other diseases. Recurrence-free survival was calculated using the Kaplan–Meier method. Survival curves were compared using the log-rank test. Predictive factors were evaluated using univariate and multivariate analyses.
Results
Nine patients experienced recurrence. A significant difference in recurrence-free survival was detected between patients with and without a positive preoperative sputum culture (P = 0.000942). Moreover, patients with a positive preoperative sputum smear (≥ 2 +) had a significantly higher recurrence rate than those who did not (P = 0.000216). Multivariate analysis revealed that preoperative sputum smear (≥ 2 +) is an independent risk factor for recurrence after pulmonary resection for NTMPD (odds ratio, 7.38; 95% confidential interval, 1.29–42.2; P = 0.024).
Conclusions
NTM discharge might have an impact on postoperative recurrence of NTMPD patients without residual cavitary lesions. Preoperative NTM discharge should be minimized by optimizing medical therapy before surgical treatment to improve the postoperative course. Intensive follow-up and prolonged postoperative medical therapy should be considered for patients without a sufficient reduction in bacterial discharge before pulmonary resection.
Similar content being viewed by others
References
Adjemian J, Oliver KN, Seitzs AE, Holland SM, Prevots DR. Prevalence of nontuberculous mycobacterial lung disease in U.S. Medicare beneficiaries. Am J Respir Crit are Med. 2012;185:881–6.
Henry MT, Rivlin J, Shalit I, Ephros M, Blau H. Nontuberculous mycobacteria in non-HIV patients: epidemiology, treatment and response. Eur Respir J. 2004;23:741–6.
Dailloux M, Abalain ML, Laurain C, Lebrun L, Loos-Ayav C, Lozniewski A, et al. Respiratory infections associated with nontuberculous mycobacteria in non-HIV patients. Eur Respir J. 2006;28:1211–5.
Griffith DE, Aksamit T, Brown-Elliott BA, Catanzaro A, Daley C, Gordin F, et al. An official ATS/IDSA statement: diagnosis, treatmet and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med. 2007;175:367–416.
Weber A, Stammberger U, Inci I, Schmid RA, Dutly A, Weder W. Thoracoscopic lobectomy for benign disease-a single centre study on 64 cases. Eur J Cardiothorac Surg. 2001;20:443–8.
Zhang P, Zhang F, Jiang S, Jiang G, Zhou X, Ding J, et al. Video-assisted thoracic surgery for bronchiectasis. Ann Thorac Surg. 2011;91:239–43.
Sakane T, Matsuoka K, Kumata S, Watanabe R, Yamada T, Matsuoka T, et al. The outcomes of anatomical lung resection for nontuberculous mycobacterial lung disease. J Thorac Dis. 2018;10:954–62.
Chang KC, Leung CC, Yew WW, et al. A nested case control study on treatment-related risk factors for early relapse of tuberculosis. Am J Respir Crit Care Med. 2004;170:1124–30.
Chang KC, Leung CC, Yew WW, Chan SL, Tam CM. Dosing schedules of 6-month regimens and relapse for pulmonary tuberculosis. Am J Respir Crit Care Med. 2006;174:1153–8.
Jo KW, Yoo JW, Hong Y, Lee JS, Lee SD, Kim WS, et al. Risk factors for 1-year relapse of pulmonary tuberculosis treated with a 6-month daily regimen. Respir Med. 2014;108:654–9.
Diagnostic Standards and Classification of Tuberculosis in Adults and Children. This official statement of the American Thoracic Society and the Centers for Disease Control and Prevention was adopted by the ATS Board of Directors. This statement was endorsed by the Council of the Infectious Disease Society of America, September 1999. Am J Respir Crit Care Med. 1999;2000(161):1376–95.
Shiraishi Y, Katsuragi N, Kita H, Hyogotani A, Saito MH, Shimoda K. Adjuvant surgical treatment of nontuberculous mycobacterial lung disease. Ann Thorac Surg. 2013;96:287–92.
Wallace RJ Jr, Brown-Elliot BA, McNulty S, Philley JV, Killingley J, Wilson RW, et al. Marcrolide/azalide therapy for nodular/bronchiectatic Mycobacterium avium complex lung disease. Chest. 2014;146:276–82.
Jarand J, Levin A, Zhang L, Huitt G, Mitchell JD, Daley CL. Clinical and microbiologic outcomes in patients receiving treatment for Mycobacterium abscessus pulmonary disease. Clin Infect Dis. 2011;52:565–71.
Van Lngen J, Verhagen AF, Dekhuijzen PN, van Soolingen D, Magis-Escurra C, Boeree MJ, et al. Surgical treatment of non-tuberculus nycobacterial lung disease: strike in time. Int J Tuberc Lung Dis. 2010;14:99–105.
Mitchell JD, Yu JA, Bishop A, Weyant MJ, Pomerantz M. Thoracoscopic lobectomy and segmentectomy for infectious lung disease. Ann Thorac Surg. 2012;93:1033–40.
Koh WJ, Kim YH, Kwon OJ, Choi YS, Kim K, Shim YM, et al. Surgical treatment of pulmonary diseases due to nontuberculous mycobacteria. J Korean Med Sci. 2008;23:397–401.
Yu JA, Pomerantz M, Bishop A, Weyant MJ, Mitchell JD. Lady Windermere revisited: treatment with thoracoscopic lobectomy/segmentectomy for right middle lobe and lingular bronchiectasis associated with non-tuberculous mycobacterial disease. Eur J Cardiothorac Surg. 2011;40:671–5.
Yamada K, Seki Y, Nakagawa T, Hayashi Y, Yagi M, Ogawa K. Outcomes and risk factors after adjuvant surgical treatments for Mycobacterium avium complex lung disease. Gen Thorac Cardiovasc Surg. 2019;67:363–9.
Asakura T, Hayakawa N, Hasegawa N, Namkoong H, Takeuchi K, Suzuki S, et al. Long-term outcome of pulmonary resection for nontuberculous mycobacterial pulmonary disease. Clin Infect Dis. 2017;65:244–51.
Canetti G. Present aspect of bacterial resistance in tuberculosis. Am Rev Respir Dis. 1965;92:687–703.
Palaci M, Dietze R, Hadad DJ. Cavitary disease and quantitative sputum bacillary load in case of pulmonary tuberculosis. J Clin Microbiol. 2007;45:4064–6.
Lee BY, Kim S, Hong Y, Lee SD, Kim WS, Kim DS, et al. Risk factors for recurrence after successful treatment of Mycobacterium avium complex lung disease. Antimicrob Agents Chemother. 2015;5:2972–7.
Wallace RJ Jr, Brown-Elliott BA, McNulty S, Philley JV, Killingley J, Wilson RW, et al. Macrolide/azalide therapy for nodular/bronchiectatic Mycobacterium avium complex lung disease. Chest. 2014;146:276–82.
Colombo RE, Hill SC, Claypool RJ, Holland SM, Olivier KN. Familial clustering of pulmonary nontuberculous mycobacterial disease. Chest. 2010;137:629–34.
Yamada K, Yasuda A, Seki Y, Fukui Y, Yagi M, Tarumi O, et al. Risk factors for recurrence after surgical treatment of nontuberculous mycobacterial lung disease. Kekkaku. 2017;92:451–7.
Han D, Lee KS, Yi CA, Kim TS, Kwon OJ. Radiographic and CT findings of nontuberculous mycobacterial pulmonary infection caused by Mycobactrium abscessus. AJR Am J Roentqenol. 2003;181:513–7.
Funding
There was no funding from any organizations or companies. Notation of prior abstract publication/presentation: None.
Author information
Authors and Affiliations
Contributions
Yotsumoto T contributed to data collection, data analysis, and wrote the initial draft of the manuscript. Inoue Y and Fukami T designed the study, contributed to data analysis and interpretation, and assisted in the preparation of the manuscript.
Corresponding author
Ethics declarations
Conflict of interest
None declared.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Yotsumoto, T., Inoue, Y., Fukami, T. et al. Pulmonary resection for nontuberculous mycobacterial pulmonary disease: outcomes and risk factors for recurrence. Gen Thorac Cardiovasc Surg 68, 993–1002 (2020). https://doi.org/10.1007/s11748-020-01326-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11748-020-01326-1